Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema following Central Retinal Vein Occlusion: 1 Initial Injection versus 3 Monthly Injections. [electronic resource]
Producer: 20180202Description: 27-35 p. digitalISSN:- 1423-0267
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Fundus Oculi
- Humans
- Intravitreal Injections
- Macula Lutea -- pathology
- Macular Edema -- diagnosis
- Male
- Middle Aged
- Prospective Studies
- Ranibizumab -- administration & dosage
- Retinal Vein Occlusion -- complications
- Time Factors
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.